A carregar...
Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6–35 Months: A Randomized, Controlled Trial
BACKGROUND. Improved influenza vaccine strategies for infants and preschool children are a high priority. METHODS. The immunological response and safety of a thimerosal-free trivalent inactivated influenza vaccine at 2 different doses (0.50 mL vs 0.25 mL) was evaluated in children aged 6–35 months....
Na minha lista:
Main Authors: | , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Oxford University Press
2012
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3656551/ https://ncbi.nlm.nih.gov/pubmed/23687572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jpids/pis012 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|